Two weeks ago, the Cellix team travelled to Prague to participate in Cyto 2018, a conference discussing the cutting edge of flow cytometry research.

In the final of a 4 part series, we are discussing the comments of industry leaders at the conference, and companies to watch in this space.

Over the course of Cyto 2018, I met with some of the people at the forefront of the field, and particularly at t...

Two weeks ago, the Cellix team travelled to Prague to participate in Cyto 2018, a conference discussing the cutting edge of flow cytometry research.

In the third of a 4 part series, we're looking at innovative applications for gene therapy.

One of the end goals of any field aimed at human therapeutics is the eradication of disease. However, diseases such as HIV currently can't be cured, and treatmen...

Two weeks ago, the Cellix team travelled to Prague to participate in Cyto 2018, a conference discussing the cutting edge of flow cytometry research. In the second of a 4 part series, here's our key take-aways from the conference.

As I mentioned in a previous post, one of the most interesting points differentiating Cyto 2018 from previous years was the focus on flow cytometry use in human gene thera...